Myers S - Search Results

1

Human naive epiblast cells possess unrestricted lineage potential.

Guo G, Stirparo GG, Strawbridge SE, Spindlow D, Yang J, Clarke J, Dattani A, Yanagida A, Li MA, Myers S, Özel BN, Nichols J, Smith A. Guo G, et al. Among authors: myers s. Cell Stem Cell. 2021 Jun 3;28(6):1040-1056.e6. doi: 10.1016/j.stem.2021.02.025. Epub 2021 Apr 7. Cell Stem Cell. 2021. PMID: 33831366 Free PMC article.

2

Epigenetic resetting of human pluripotency.

Guo G, von Meyenn F, Rostovskaya M, Clarke J, Dietmann S, Baker D, Sahakyan A, Myers S, Bertone P, Reik W, Plath K, Smith A. Guo G, et al. Among authors: myers s. Development. 2017 Aug 1;144(15):2748-2763. doi: 10.1242/dev.146811. Development. 2017. PMID: 28765214 Free PMC article.

3

A reappraisal of the role of cerium in burn wound management.

Lansdown AB, Myers SR, Clarke JA, O'Sullivan P. Lansdown AB, et al. Among authors: myers sr. J Wound Care. 2003 Mar;12(3):113-8. doi: 10.12968/jowc.2003.12.3.26480. J Wound Care. 2003. PMID: 12677874 Review.

4

Correction: Epigenetic resetting of human pluripotency (doi:10.1242/dev.146811).

Guo G, von Meyenn F, Rostovskaya M, Clarke J, Dietmann S, Baker D, Sahakyan A, Myers S, Bertone P, Reik W, Plath K, Smith A. Guo G, et al. Among authors: myers s. Development. 2018 Apr 18;145(8):dev166397. doi: 10.1242/dev.166397. Development. 2018. PMID: 29669738 Free PMC article. No abstract available.

5

Has the name PCOS run its course?

Myers SH, Forte G, Unfer V. Myers SH, et al. Arch Gynecol Obstet. 2024 Jun 5. doi: 10.1007/s00404-024-07571-6. Online ahead of print. Arch Gynecol Obstet. 2024. PMID: 38836930 No abstract available.

6

Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer.

Mai N, Myers S, Shen S, Downs-Canner S, Robson M, Norton L, Chen Y, Traina T, Abuhadra N. Mai N, et al. Among authors: myers s. NPJ Breast Cancer. 2024 Jun 4;10(1):39. doi: 10.1038/s41523-024-00643-5. NPJ Breast Cancer. 2024. PMID: 38834621 Free PMC article.

7

ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.

Myers SP, Sevilimedu V, Jones VM, Abuhadra N, Montagna G, Plitas G, Morrow M, Downs-Canner SM. Myers SP, et al. Ann Surg Oncol. 2024 Jun 4. doi: 10.1245/s10434-024-15491-7. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38833059 No abstract available.

8

In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency.

Kubota CS, Myers SL, Seppälä TT, Burkhart RA, Espenshade PJ. Kubota CS, et al. Among authors: myers sl. Mol Metab. 2024 May 30:101964. doi: 10.1016/j.molmet.2024.101964. Online ahead of print. Mol Metab. 2024. PMID: 38823776 Free article.

9

ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation.

Myers SP, Downs-Canner SM. Myers SP, et al. Ann Surg Oncol. 2024 May 22. doi: 10.1245/s10434-024-15445-z. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38776008 No abstract available.

10

Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.

Myers SP, Sevilimedu V, Jones VM, Abuhadra N, Montagna G, Plitas G, Morrow M, Downs-Canner SM. Myers SP, et al. Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15359-w. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38767803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,933 results

Search Page